Streetbeat News

Stock Prices

SE

High-rolling investors are showing a bullish sentiment on Sea Limited (NYSE:SE) through significant options trading activity. Benzinga's options scanner detected 10 trades, with 60% being bullish. The stock price is currently up by 3.98% at $89.12, and the RSI indicates it may be approaching overbought territory.

Portfolio Pulse from Benzinga Insights

September 23, 2024 | 2:16 pm

CORZ

Whales are showing a bullish stance on Core Scientific (NASDAQ:CORZ) with 72% of recent options trades being bullish. Analysts have set an average price target of $17.25, with some downgrades in ratings. The stock is currently trading at $12.36, up by 3.17%.

Portfolio Pulse from Benzinga Insights

September 23, 2024 | 2:16 pm

NVO

Novo Nordisk shares are experiencing a decline following criticism from US Senator Bernie Sanders regarding the pricing of their weight loss drug.

Portfolio Pulse from Benzinga Newsdesk

September 23, 2024 | 2:15 pm

SPY

Federal Reserve's Goolsbee anticipates multiple rate cuts over the next year, emphasizing the Fed's focus on employment risks rather than just inflation. With inflation down from its peak and a strong labor market, maintaining high rates is deemed unnecessary. Significant rate reductions are needed to achieve a soft landing.

Portfolio Pulse from Benzinga Newsdesk

September 23, 2024 | 2:14 pm

KAVL

Kaival Brands Innovations Group experienced a significant stock price surge, leading to a trading halt due to a circuit breaker. The stock is now up by 219.5%.

Portfolio Pulse from Benzinga Newsdesk

September 23, 2024 | 2:13 pm

MBRX

Moleculin Biotech's shares rose following the presentation of promising data on Annamycin at IASLC 2024, highlighting its effectiveness in inhibiting tumor growth and extending survival in lung cancer patients, with no cardiotoxicity.

Portfolio Pulse from Benzinga Newsdesk

September 23, 2024 | 2:12 pm

GM

NVO

Oil prices increased due to tensions in the Middle East. Bernstein downgraded General Motors (GM) stock, and Novo Nordisk (NVO) faced a decline following pricing criticism from Senator Sanders.

Portfolio Pulse from Benzinga Newsdesk

September 23, 2024 | 2:10 pm

FRGT

Freight Technologies announced a 1-for-25 reverse stock split, leading to a decline in its share price.

Portfolio Pulse from Benzinga Newsdesk

September 23, 2024 | 2:10 pm

IDYA

PFE

Ideaya Biosciences' stock fell 5.3% despite promising interim Phase 2 data for its eye cancer drug, darovasertib. The data showed significant tumor shrinkage and eye preservation rates. Ideaya plans a Phase 3 trial with FDA guidance. The drug is also being tested in collaboration with Pfizer.

Portfolio Pulse from Vandana Singh

September 23, 2024 | 2:07 pm

STLA

Stellantis aims to reduce its North American inventories by 100,000 units by early 2025, as stated by the company's CFO at the 2024 Bank of America European Autos and Future Car Virtual Conference.

Portfolio Pulse from Benzinga Newsdesk

September 23, 2024 | 2:06 pm